https://doctransparency.com/doctor/tx/arlington/angela-moore-1235142266
Medicare Enrolled

Dr. Angela Moore, MD, PA

Dermatology · Arlington, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
711 E LAMAR BLVD STE 200, Arlington, TX 76011
8177957546
In practice since 2006 (19 years)
NPI: 1235142266 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Moore from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Moore? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Moore

Dr. Angela Moore is a dermatology in Arlington, TX, with 19 years in practice. Based on federal Medicare data, Dr. Moore performed 60,173 Medicare services across 2,727 unique beneficiaries.

Between the years covered by Open Payments, Dr. Moore received a total of $495,333 from 57 pharmaceutical and/or device companies across 1321 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Moore is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 0% volume in TX$ $495,333 industry payments

Medicare Practice Summary

Medicare Utilization ↗
60,173
Medicare services
Top 0% in TX for dermatology
2,727
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,167 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Photodynamic therapy gel for precancerous skin51,200$1$2
Test for allergy using skin patch3,500$4$6
Destruction of precancer skin growth, 15 or more growths979$128$171
Destruction of skin growth, 15 or more growths832$96$135
Tissue pathology examination, moderate complexity810$52$72
Pathology examination of tissue using a microscope, moderately high complexity382$226$289
Destruction of precancerous skin growths, 2-14360$5$7
Therapy procedure using ultraviolet radiation with tar or petroleum jelly application343$93$120
Application of light with debridement to destroy precancer skin growth255$221$293
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm222$230$308
Skin biopsy, tangential213$70$105
New patient office or other outpatient visit, 15-29 minutes145$46$74
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm136$94$250
Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm86$229$316
Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm84$242$321
Destruction of skin growths (warts/lesions), 1-1482$88$115
Office visit, established patient (10-19 min)66$42$57
Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm63$103$284
Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm62$106$273
Destruction of precancerous skin growth, 156$25$68
Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm51$100$259
Office visit, established patient (20-29 min)43$59$91
Biopsy of related skin growth, each additional growth40$40$54
Punch biopsy, first skin growth35$77$132
Office visit, established patient (30-39 min)32$85$132
Destruction of growth of eyelid margin, 1.0 cm or less26$166$220
Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm19$117$303
New patient office visit (30-44 min)19$52$113
Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm16$117$322
Pathology examination of tissue using a microscope, moderately low complexity16$31$42
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$495,333
Total received (2018-2024)
Avg $70,762/year across 7 years
Top 2% in TX for dermatology
57
Companies
1,321
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$403,552 (81.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$72,369 (14.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,412 (3.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$50,555
2023
$55,897
2022
$84,732
2021
$46,475
2020
$52,594
2019
$115,344
2018
$89,735

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Almirall LLC
$133,023
AbbVie, Inc.
$98,224
VYNE Pharmaceuticals Inc.
$70,139
Verrica Pharmaceuticals Inc.
$46,062
Incyte Corporation
$35,185
PFIZER INC.
$12,586
Biofrontera Inc.
$12,136
LEO Pharma Inc.
$9,654
Allergan Inc.
$9,056
AbbVie Inc.
$8,232
Galderma Laboratories, L.P.
$7,446
Janssen Biotech, Inc.
$7,076
Aclaris Therapeutics, Inc.
$6,734
E.R. Squibb & Sons, L.L.C.
$6,291
LEO Pharma AS
$4,499
Takeda Pharmaceuticals U.S.A., Inc.
$3,836
Janssen Global Services, LLC
$3,439
Fresenius Kabi USA, LLC
$3,079
EPI Health, LLC
$2,663
Novartis Pharmaceuticals Corporation
$2,648
ABBVIE INC.
$1,800
Mayne Pharma Inc.
$1,680
Janssen Scientific Affairs, LLC
$1,412
Sun Pharmaceutical Industries Inc.
$1,365
Lilly USA, LLC
$973
MAYNE PHARMA INC.
$933
UCB, Inc.
$780
Arcutis Biotherapeutics, Inc.
$600
Celgene Corporation
$387
MAYNE PHARMA COMMERCIAL LLC
$305
Sandoz Inc.
$304
GENZYME CORPORATION
$302
Amgen Inc.
$281
GlaxoSmithKline, LLC.
$234
Exeltis, USA Inc.
$219
DERMIRA, INC.
$188
Encore Dermatology Inc.
$182
Paratek Pharmaceuticals, Inc.
$173
Ortho Dermatologics, a division of Bausch Health US, LLC
$139
Janssen Research & Development, LLC
$131
Actelion Pharmaceuticals US, Inc.
$125
SUN PHARMACEUTICAL INDUSTRIES INC.
$111
Sebela Pharmaceuticals Inc.
$101
Journey Medical Corporation
$90
Dermavant Sciences, Inc.
$86
Tempus AI, Inc
$72
Regeneron Healthcare Solutions, Inc.
$65
Abbott Laboratories
$59
DUSA Pharmaceuticals, Inc.
$40
Allergan, Inc.
$40
Acrotech Biopharma LLC
$34
Elekta, Inc.
$33
Promius Pharma LLC
$23
Nabriva Therapeutics, plc
$19
Genentech USA, Inc.
$19
Mylan Pharmaceuticals Inc.
$12
Pierre Fabre Pharmaceuticals, Inc.
$8
Top 3 companies account for 60.8% of total payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ADBRY · AKLIEF · AMELUZ · AMZEEQ · Absorica LD · Acticlate · Aczone · Ameluz · BENLYSTA · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · BOTOX · BOTOX COSMETIC · Bimzelx · CIBINQO · CLODERM · COSENTYX · CardioMEMS HF System · Cimzia · Clindamycin Phosphate and Benzoyl Peroxide · Cordran · DORYX · DUOBRII · DUPIXENT · ELEKTA MEDICAL LINEAR ACCELERATOR · ENSTILAR · EPIDUO FORTE · EUCRISA · Ecoza · Enbrel · Erivedge · HUMIRA · HYRIMOZ · Humira · IDACIO · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Impoyz · JUBLIA · KERYDIN · KLISYRI · KYBELLA · Klisyri · LIBTAYO · LITFULO · Merlin Test · NAFTIN · NUZYRA · ODOMZO · OLUMIANT · OPZELURA · OXISTAT · Otezla · PICATO · PRAMOSONE · Pacemakers · QBREXZA · REMICADE · RHOFADE · RINVOQ · SEYSARA · SILIQ · SKYRIZI · SOOLANTRA · STELARA · Sernivo · Seysara · Sitavig · Sivextro · Skyrizi · Sotyktu · TALTZ · TREMFYA · Tremfya · UPTRAVI · VECTICAL · VEREGEN · VTAMA · Veltin · WYNZORA · Winlevi · XELJANZ · Xolegel · YCANTH · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (82%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in dermatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for dermatology in TX.

Equivalent to $823 per 100 Medicare services performed
Looking for a dermatology in Arlington?
Compare dermatologys in the Arlington area by procedure volume, costs, and industry payment transparency.
Browse dermatologys nearby

Geographic Context

Dermatologys within 10 mi
181
Per 100K population
8.5
County median income
$81,905
Nearest hospital
MILLWOOD HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Moore is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), and high industry engagement (speaking/promotional, top 2%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Moore experienced with photodynamic therapy gel for precancerous skin?
Based on Medicare claims data, Dr. Moore performed 51,200 photodynamic therapy gel for precancerous skin services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Moore receive payments from pharmaceutical companies?
Yes. Dr. Moore received a total of $495,333 from 57 companies across 1,321 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Moore's costs compare to other dermatologys in Arlington?
Dr. Moore's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Moore) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →